Vela Diagnostics this week announced the CE-IVD launch of its Sentosa SA Direct MRSA/SA PCR test.

The new test uses real-time PCR to qualitatively detect and differentiate Staphylococcus aureus and methicillin-resistant S. aureus from nasal swabs in patients at risk for nasal colonization, to aid in the prevention and control of MRSA/SA infections in healthcare settings, Singapore-based Vela said.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.